Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03
Nyrada Inc has completed an in-vivo micronucleus on the effects of its NYR-BI03 drug on rats, suggesting it causes no genetic damage
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
PPH | Ann: Removal from Official List | 19/05/23 | 0 | 831 | |||
|
|||||||
PPH | Ann: Pushpay Scheme Implemented | 19/05/23 | 0 | 857 | |||
|
|||||||
PPH | Ann: Suspension from Official Quotation | 10/05/23 | 0 | 493 | |||
|
|||||||
PPH | Ann: Sealed Final Orders | 10/05/23 | 0 | 512 | |||
|
|||||||
PPH | Ann: Pushpay receives sealed Final Orders for Scheme... | 10/05/23 | 0 | 462 | |||
|
|||||||
PPH | Ann: Ceasing to be a substantial holder | 08/05/23 | 0 | 337 | |||
|
|||||||
PPH | Ann: Change in substantial holding | 08/05/23 | 0 | 267 | |||
|
|||||||
PPH | Ann: Change in substantial holding | 08/05/23 | 0 | 248 | |||
|
See All Discussions